Hm Payson & CO Takeda Pharmaceutical CO LTD Transaction History

Hm Payson & CO

$5.37 Billion
Q1 2024

A detailed history of Hm Payson & CO transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Hm Payson & CO holds 100 shares of TAK stock, worth $1,303. This represents 0.0% of its overall portfolio holdings.

Number of Shares

100

Previous 286 65.03%

Holding current value

$1,303

Previous $4,000 75.0%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Jun 20, 2024	SELL	$13.89 - $15.04 $2,583 - $2,797	-186 Reduced 65.03%	100 $1,000
Q4 2023 Feb 13, 2024	SELL	$13.36 - $15.43 $6,720 - $7,761	-503 Reduced 63.75%	286 $4,000
Q3 2023 Nov 06, 2023	BUY	$15.03 - $16.32 $7,560 - $8,208	503 Added 175.87%	789 $12,000
Q1 2023 Apr 18, 2023	SELL	$15.28 - $16.48 $1,604 - $1,730	-105 Reduced 26.85%	286 $4,000
Q4 2022 Feb 06, 2023	BUY	$12.42 - $15.62 $1,304 - $1,640	105 Added 36.71%	391 $6,000

Q1 2022 May 12, 2022	SELL	$13.54 - $15.35 $10,087 - $11,435	-745 Reduced 72.26%	286 $4,000
Q2 2021 Aug 17, 2021	SELL	$16.55 - $18.64 $165 - $186	-10 Reduced 0.96%	1,031 $17,000
Q1 2020 Jul 01, 2020	SELL	$13.02 - $20.31 $3,268 - $5,097	-251 Reduced 19.43%	1,041 $16,000
Q4 2019 Feb 18, 2020	SELL	$16.88 - $20.83 $33,439 - $41,264	-1,981 Reduced 60.53%	1,292 $25,000
Q3 2019 Nov 12, 2019	SELL	$16.15 - $17.99 $19,961 - $22,235	-1,236 Reduced 27.41%	3,273 $56,000
Q2 2019 Aug 15, 2019	BUY	$16.58 - $20.49 $74,759 - $92,389	4,509 New	4,509 $80,000

Others Institutions Holding TAK

# of Institutions

341

Shares Held

76M

Call Options Held

1.85M

Put Options Held

121K

View Full List

About TAKEDA PHARMACEUTICAL CO LTD

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $40.5B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

More about TAK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hm Payson & CO, based on Form 13F filings with the SEC.

News

Stay updated on Hm Payson & CO with notifications on news.

Account